These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34385616)

  • 21. [Role of anti-CCR4 antibody in the treatment of transplant-eligible patients with aggressive adult T-cell leukemia/lymphoma].
    Fuji S
    Rinsho Ketsueki; 2018; 59(4):426-431. PubMed ID: 29743403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma exchange following mogamulizumab therapy before bone marrow transplantation in refractory adult T-cell leukemia-lymphoma.
    Shimazu Y; Nohgawa M
    Leuk Lymphoma; 2019 Dec; 60(12):3092-3093. PubMed ID: 31104532
    [No Abstract]   [Full Text] [Related]  

  • 23. An update on the developments in the treatment of adult T-cell leukemia-lymphoma: current knowledge and future perspective.
    Makiyama J; Ishitsuka K; Munakata W; Maruyama D; Nagai H
    Jpn J Clin Oncol; 2023 Dec; 53(12):1104-1111. PubMed ID: 37592900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis.
    Fuji S; Kurosawa S; Inamoto Y; Murata T; Utsunomiya A; Uchimaru K; Yamasaki S; Inoue Y; Moriuchi Y; Choi I; Ogata M; Hidaka M; Yamaguchi T; Fukuda T
    Bone Marrow Transplant; 2018 Jul; 53(7):905-908. PubMed ID: 29371687
    [No Abstract]   [Full Text] [Related]  

  • 25. Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality.
    Fuji S; Inoue Y; Utsunomiya A; Moriuchi Y; Uchimaru K; Choi I; Otsuka E; Henzan H; Kato K; Tomoyose T; Yamamoto H; Kurosawa S; Matsuoka K; Yamaguchi T; Fukuda T
    J Clin Oncol; 2016 Oct; 34(28):3426-33. PubMed ID: 27507878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia/lymphoma.
    Haji S; Kiyasu J; Choi I; Suehiro Y; Toyoda K; Tsuda M; Takamatsu A; Nakashima Y; Miyoshi H; Shiratsuchi M; Yamasaki S; Uike N; Abe Y
    Bone Marrow Transplant; 2016 Mar; 51(3):432-4. PubMed ID: 26524267
    [No Abstract]   [Full Text] [Related]  

  • 27. [Successful umbilical cord blood hematopoietic stem cell transplantation in a patient with adult T-cell leukemia/lymphoma initially achieving complete remission with anti-CC chemokine receptor 4 antibody combined chemotherapy].
    Suwabe T; Shibasaki Y; Kaihatsu A; Katagiri T; Miyakoshi S; Fuse K; Kobayashi H; Ushiki T; Moriyama M; Takizawa J; Narita M; Sone H; Masuko M
    Rinsho Ketsueki; 2017; 58(1):32-36. PubMed ID: 28190863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma.
    Iyama S; Sato T; Ohnishi H; Kanisawa Y; Ohta S; Kondo T; Mori A; Tsutsumi Y; Kuroda H; Kakinoki Y; Yamamoto S; Takahashi T; Shindo M; Torimoto Y; Sato K; Iwasaki H; Haseyama Y; Kohda K; Nagamachi Y; Hirayama Y; Sakai H; Hirata Y; Fukuhara T; Ikeda H; Kobune M; Kato J; Kurosawa M
    Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):23-30.e2. PubMed ID: 27727135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances in Therapeutic Approaches for Adult T-cell Leukemia/Lymphoma.
    Kato K; Akashi K
    Viruses; 2015 Dec; 7(12):6604-12. PubMed ID: 26694446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adult T-Cell Leukemia/Lymphoma.
    Mehta-Shah N; Ratner L; Horwitz SM
    J Oncol Pract; 2017 Aug; 13(8):487-492. PubMed ID: 28796966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of post-transplant relapsed adult T cell leukemia after cord blood transplantation with low-dose, short-term lenalidomide.
    Ando T; Kojima K; Sano H; Kidoguchi K; Kusaba K; Yoshimura M; Yokoo M; Kubota Y; Nakamura H; Takase Y; Aishima S; Kimura S
    Leuk Lymphoma; 2018 Oct; 59(10):2474-2477. PubMed ID: 29382244
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
    Kawano N; Yoshida S; Kuriyama T; Tahara Y; Yamashita K; Nagahiro Y; Kawano J; Koketsu H; Toyofuku A; Manabe T; Beppu K; Ono N; Himeji D; Yokota-Ikeda N; Inoue S; Ochiai H; Sonoda KH; Shimoda K; Ishikawa F; Ueda A
    Intern Med; 2015; 54(12):1489-98. PubMed ID: 26073237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient proliferation of donor-derived ATL cell-like lymphocytes early after allogeneic stem cell transplantation in an adult T-cell leukemia/lymphoma patient.
    Taguchi M; Imaizumi Y; Taguchi J; Imanishi D; Sasaki D; Hasegawa H; Tsushima H; Hata T; Miyazaki Y
    Blood; 2013 May; 121(21):4428-30. PubMed ID: 23704050
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma exchange eliminates residual mogamulizumab but does not warrant prompt recovery of peripheral Treg levels.
    Sugiura H; Matsuoka KI; Sando Y; Meguri Y; Ikegawa S; Nakamura M; Iwamoto M; Yoshioka T; Asano T; Kondo E; Fujii K; Fujii N; Maeda Y
    Transfus Apher Sci; 2019 Aug; 58(4):472-474. PubMed ID: 31303512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
    Katsuya H; Ishitsuka K
    J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.
    Fujiwara H; Fuji S; Wake A; Kato K; Takatsuka Y; Fukuda T; Taguchi J; Uchida N; Miyamoto T; Hidaka M; Miyazaki Y; Tomoyose T; Onizuka M; Takanashi M; Ichinohe T; Atsuta Y; Utsunomiya A;
    Bone Marrow Transplant; 2017 Mar; 52(3):484-488. PubMed ID: 28067877
    [No Abstract]   [Full Text] [Related]  

  • 37. [Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma].
    Utsunomiya A
    Rinsho Ketsueki; 2016; 57(10):2190-2198. PubMed ID: 27795530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mogamulizumab for the treatment of T-cell lymphoma.
    Makita S; Tobinai K
    Expert Opin Biol Ther; 2017 Sep; 17(9):1145-1153. PubMed ID: 28649848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adult T cell leukemia/lymphoma (ATL)].
    Tanosaki R
    Nihon Rinsho; 2003 Sep; 61(9):1592-5. PubMed ID: 14515729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission.
    Hirosawa M; Yamaguchi T; Tanaka A; Kominato Y; Higashi T; Morimoto H; Tsukada J
    Ann Hematol; 2020 Mar; 99(3):599-607. PubMed ID: 32006150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.